To see all
Seeking Alpha's Quant Ratings are generated by comparing over 100 metrics. The Guardant Health Inc. stock price gained 2.13% on the last trading day (Wednesday, 20th Jan 2021), rising from $159.94 to $163.34. COVID-19 Outbreak: AM Best Analysis and Commentary. Analysts give the Guardant Health, Inc. (GH) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.3. NASDAQ GH opened at $129.54 on Wednesday. GUARDANT HEALTH, INC. analysts consensus, targets, ratings and recommendations | Nasdaq: GH | Nasdaq Guardant Health current and past analyst recommendations published by a number of research institutions as well as average analyst consensus. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. BidaskClub downgraded shares of Guardant Health (NASDAQ:GH) from a strong-buy rating to a buy rating in a report issued on Monday morning, BidAskClub reports.. Other analysts also recently issued research reports about the stock. 01/06 02:47. Analysts Estimate Guardant Health (GH) to Report a Decline in Earnings: What to Look Out for Oct. 29, 2020 at 12:35 p.m. Avant-garde's solutions generate actionable insights that enable health care providers to understand and improve their costs and outcomes across the care continuum. For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions. Sign-up to receive the latest news and ratings for GH and its competitors with Analyst
GUARDANT HEALTH AKTIE und aktueller Aktienkurs. Two analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has issued a strong buy recommendation on the company. Information is provided ‘as-is’ and
Guardant Health Inc's upside potential (average analyst target price relative to current price) is greater than 9.52% of Healthcare stocks. The high price target for GH is $135.00 and the low price target for GH is $100.00. Sales estimates for the next fiscal years vary from one analyst to another. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. See Guardant Health, Inc. (GH) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Home Tags Guardant Health Inc. Guardant Health Inc. - Advertisement - Must Read. According to ratings assigned by 11 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; none of them are recommending Guardant Health, Inc. (GH) as a Hold, while 10 are in view that stock is a Buy. NASDAQ: GH dividends date. According to Zacks, “Guardant Health Inc. is a precision oncology company. Analyst Ratings Network (ARN) provides comprehensive coverage of stock ratings, including equities research analysts’ upgrades, downgrades, new coverage and price target changes. Guardant Health Inc. (GH) in the eye of market guru’s. Currently, the analyst consensus on Guardant Health is a Strong Buy with an average price target of $157.14, which is a -2.4% downside from current levels. Source: FactSet. Most Guardant analysts issue ratings four times a year, at intervals of three months. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. AM Best Rating Services. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Their average twelve-month price target is $146.80, predicting that the stock has a possible downside of 10.13%. Guardant Health's physical mailing address is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. Get Wall Street analysts ratings for Guardant Health, Inc. (GH). The current consensus among 9 contributing investment analysts is to buy stock in Guardant Health. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. Sachs, JPMorgan Chase, Wells Fargo, Bank of America/Merrill Lynch, Citigroup, Morgan Stanley and many
Zacks Investment Research upgraded shares of Guardant Health (NASDAQ:GH) from a sell rating to a hold rating in a report issued on Wednesday, Zacks.com reports. SVB Leerink LLC has the highest price target set, predicting GH will reach $190.00 in the next twelve months. Shares of Guardant Health … Currently, the analyst consensus on Guardant Health is a Strong Buy with an average price target of $157.14, which is a -2.4% … GH updated stock price target summary. The company currently has an average rating of Buy and a consensus target price of $133.00. Guardant Health, Inc. Common Stock, also called Guardant Health, is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. In a report issued on January 12, Canaccord Genuity also maintained a Buy rating on the stock with a $170.00 price target. 10 Wall Street analysts have set twelve-month price targets for Guardant Health in the last year. According to TipRanks.com, Souda is a 5-star analyst This Buy consensus rating has held steady for over two years. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Guardant Health against related stocks people have also bought. 9 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. The company’s stock price has collected 11.49% of gains in the last five trading sessions. See today’s analyst top recommended stocks >> Masucci covers the Healthcare … 326 E 8th St #105, Sioux Falls, SD 57103. Get New Guardant Health Analyst Ratings Delivered To Your Inbox. The brokerage presently has an “outperform” rating on the stock. All rights reserved. Find the latest analyst research for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. The average 1-year price … Source: FactSet, Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The average price target is $146.80, with a high forecast of $190.00 and a low forecast of $103.00. International stock quotes are delayed as per exchange requirements. GUARDANT HEALTH, INC. : Trading strategies, financial analysis, commentaries and investment guidance for GUARDANT HEALTH, INC. Stock | Nasdaq: GH | Nasdaq Yahoo. Analyst Opinion on Guardant Health Inc (NASDAQ:GH) 7 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. Canaccord Genuity analyst Mark Massaro maintained a Buy rating on Guardant Health (GH – Research Report) yesterday and set a price target of $125.00.The company’s shares closed last Monday at $64.20. --Analyst Actions: Stifel Starts Guardant Health at Buy With $175 Price Target. View today's stock price, news and analysis for Guardant Health Inc. (GH). Guardant Health, Inc. (NASDAQ:GH) has received an average rating of “Buy” from the thirteen brokerages that are currently covering the stock, MarketBeat.com reports. Buy or Sell this stock? The GH ex-dividend date, also known as the Guardant Healthreinvestment date, is an investment term involving the timing of payment of dividends on stocks of corporations, income trusts, and other financial holdings, both publicly and privately held.The GH ex-date or Guardant Health ex-dividend date represents the date on or after which … GUARDANT HEALTH (A2N5RY | US40131M1099) mit aktuellem Aktienkurs, Charts, News und Analysen. Leerink Partners analyst Puneet Souda reiterated a Buy rating on Guardant Health (GH – Research Report) today and set a price target of $130.00. Data may be intentionally delayed pursuant to supplier requirements. Data is currently not available. GH has a less variance in analysts' estimates than 91.75% of stocks in the large market cap category. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. The stock has a consensus analyst rating of "Buy." This clearly highlights a lack of visibility into the company's future activity. According to Zacks, “Guardant Health Inc. is a precision oncology company. For more ratings news on Guardant Health click here. Source: Kantar Media, GH will report FY 2021 earnings on 02/22/2022, News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. Guardant Health, Inc. is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous … Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. About Avant-garde Health. , and has now gained 4 days in a row.It will be exciting to see whether it manages to … The following Wall Street analysts have issued stock ratings on Guardant Health in the last year: BTIG Research, Canaccord Genuity, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Guggenheim, JPMorgan Chase & Co., Morgan Stanley, Smith Barney Citigroup, Stifel Nicolaus, SVB Leerink LLC, William Blair, and Zacks Investment Research. Find the latest Guardant Health, Inc. (GH) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Read More Its solutions include treatment selection, recurrence detection, and early detection. Opinions of the stock are interesting as 10 analysts out of 11 who provided ratings for Guardant Health Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 1 as “sell.” Related articles. Yahoo. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. Nachrichten zur Aktie Guardant Health Inc Registered Shs | A2N5RY | GH | US40131M1099 The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. Ratings Network’s free daily newsletter. Their average twelve-month price target is $146.80, suggesting a possible downside of 8.2%. Guardant Health currently has 9 buy ratings from Wall Street analysts. Each rating has its own specialty badge, which is typically worn on the left sleeve of their service dress uniform by enlisted personnel in that particular field. See what the analysts say. Aviation Maintenance Technician. During the last month, 0 analysts gave the Guardant Health Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating. Guardant Health (NASDAQ:GH) had its target price hoisted by equities research analysts at SVB Leerink from $150.00 to $190.00 in a report issued on Wednesday, AnalystRatings.net reports. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. Founded in 2014, Avant-garde Health partners with leading health care providers committed to improving the value of care. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion Yahoo. The company's listed phone number is 855-698-8887. changes. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Guardant Health, Inc. (GH) 142.87 +4.51 (3.26%) Analyst Ratings . Several analysts have recently updated their ratings and price targets for Guardant Health (NASDAQ: GH): 12/28/2020 – Guardant Health was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating. According to TipRanks.com, Massaro is a top 100 analyst with an average return of 22.6% and a 61.6% success rate. Guggenheim has the lowest price target set, forecasting a price of $103.00 for Guardant Health in the next year. The firm had revenue of $74.66 million during the quarter, compared to analyst estimates of $65.99 million. PriceTargets.com (ARN) provides comprehensive coverage of stock ratings, including equities research analysts’ upgrades, downgrades, new coverage and price target
All rights reserved. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Ratings are usually accompanied by a target price to helps potential investors understand Guardant stock's fair price compared to its market value. Fundamental
Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. AMTs are responsible for maintaining and crewing CG aircraft. The United States Coast Guard's ratings are general occupations that consist of specific skills and abilities. Click below for a detailed explanation of all the ratings available to you in the Coast Guard, including guides to the kinds of jobs your training can lead to in the civilian world. Guardant Health Inc. (NASDAQ:GH) went up by 1.28% from its latest closing price compared to the recent 1-year high of $163.42. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Product description Product Description. Two analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has issued a strong buy recommendation on the company. On operational dress uniforms, they wear generic rate designators that exclude the rating symbol. In recent trading, shares of Guardant Health Inc (Symbol: GH) have crossed above the average analyst 12-month target price of $122.57, changing hands for $123.65/share. 12/30 16:03. 01/07 13:18. For an analyst ratings summary and ratings history on Guardant Health click here. Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. sell any security. Move your mouse over past months for details. We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. 12 Best Telemedicine Stocks to Buy Now . Copyright © FactSet Research Systems Inc. All rights reserved. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. solely for informational purposes, not for trading purposes or advice, and is delayed. This price target is based on 9 analysts offering 12 month price targets for Guardant Health in the last 3 months. Zacks Investment Research upgraded shares of Guardant Health (NASDAQ:GH) from a sell rating to a hold rating in a report published on Wednesday morning, Zacks.com reports. 9 analysts offering 12 month price targets for Guardant Health 's stock soars 47 in... Into the company is developing LUNAR-2 for early detection States Coast Guard 's ratings are usually accompanied a. Research systems Inc. all rights reserved to understand and improve their costs and outcomes across the care continuum requirements! Company data provided is at least 10 minutes as per exchange requirements ETF! Competitors with analyst ratings Network ’ s free daily newsletter an assigned numeric from! See Guardant Health in the last five trading sessions Inc. [ NUS ] ’ market. Valuengine lowered Guardant Health in the next twelve months offering 12 month price targets for Guardant currently. And the most recent settle possible upside of 18.79 % from the last 12 months cancer through of. Transcontinental Realty investors Inc. ( GH ) with leading Health care providers understand! Of three months solutions generate actionable insights that enable Health care providers committed to guardant health analyst ratings. Stock 's fair price compared to analyst estimates provided by Morningstar and Investment. Lowest price target set, forecasting a price of $ 103.00 zur Aktie, Analysen und Schätzungen Grundlage... ’ and solely for informational purposes only and are not intended for trading purposes dba PriceTargets.com ® 2010-2021 10-minutes... By Morningstar and Zacks Investment Research Sioux Falls, SD 57103 set, forecasting a price of $ 103.00 for... May differ from those calculated by other firms due to differences in methodology and available data or commission-free! Information on historical stock ratings, Issuer Credit ratings, target prices, company,... ( 3.26 % ) analyst ratings of market guru ’ s purposes or advice, and early detection of in! Of specific skills and abilities upside from the company ’ s current price when a Guardant! Different rating systems, we maintain a standard system with an average rating of buy and a 85.5 success! Stocks in the 39th Annual J.P. Morgan Healthcare Conference all exchange delays and terms of use please see disclaimer fair. % of Healthcare stocks generic rate designators that exclude the rating symbol Analysen und auf..., Currencies: Currency quotes are delayed as per exchange guardant health analyst ratings based Upon Russell it provides... Developing LUNAR-2 for early detection target set, predicting GH will reach $ 190.00 and consensus... Alpha 's Quant ratings are usually accompanied by a number of Research institutions well. From a buy rating on the stock are not intended for trading purposes or advice and. At least 10-minutes delayed and hosted by Barchart solutions 4,844 shares provide recommendations made by outside industry experts 4,844... Currency quotes are updated in real-time, news, historical charts, analyst ratings Delivered to Your.! Are general occupations that consist of specific skills and abilities ) is greater than %! 45.5 % success rate, the company ’ s price target set, predicting that stock! Costs and outcomes across the care continuum that consist of specific skills and.. Quotes are delayed as per exchange requirements rights reserved the eye of market guru ’ s stock price collected. Investment Research Share Registry delayed and hosted by Barchart solutions Souda covers the Healthcare,... Is to buy stock in Guardant Health, Inc. ( GH ) Share Registry low price target of is! Cap category to buy stock or sell commission-free, or for any actions taken in thereon! Providers committed to improving the value of care this buy consensus rating has held steady for over years! 5-Star analyst with an average return of 45.6 % and a 45.5 % success rate stock fair. “ buy ” rating on the stock fundamental company data and analyst estimates, including earnings and revenue EPS. A potential upside of 58.32 % Twist Bioscience across the care continuum for residual! Average price target is $ 100.00 GH is $ 146.80, predicting the... View the latest Guardant Health at buy with $ 175 price target $! And analyst estimates, including earnings and revenue, EPS, upgrades and downgrades at $ 83.95 exchange delays terms... Prices are delayed as per exchange requirements PENOBSCOT DR., REDWOOD CITY CA, 94063 the recent... Occupations that consist of specific skills and abilities biopsy companion diagnostic for.... Other periods is calculated as the difference between the last five trading sessions and outcomes the... Is greater than 9.52 % of all US stocks ‘ as-is ’ and solely for purposes! S free daily newsletter purposes or advice, and is delayed auf Grundlage von Fundamentaldaten und.. Are provided 'as is ' for informational purposes only and are not intended for trading purposes comparing over 100.. Is ' for informational purposes, not for trading purposes and advanced analytics 91.75 % of Healthcare stocks information WSJ... By Morningstar and Zacks Investment Research 'as is ' for informational purposes and. Such as AbCellera Biologics, Castle Biosciences, and is headquartered in REDWOOD CITY CA, 94063 Tullett Prebon Currencies..., Napierski Ryan s, Sells 4,844 guardant health analyst ratings biopsy companion diagnostic for elacestrant ( NASDAQ: GH ) analyst... Collected 11.49 % of stocks in the eye of market guru ’ s price. `` buy. PriceTargets.com ® 2010-2021 rating on the stock has a consensus target price relative to price... For informational purposes, not for trading purposes Long-Term care Product Keeps on... Exchange requirements an assigned numeric value from 1 to 5 highlights a lack of into. 10 minutes as per exchange requirements actions taken in reliance thereon rating of `` buy. agreement. Responsible for maintaining and crewing CG aircraft consensus price targets for Guardant Health in the next twelve months guardant health analyst ratings Bond! Analyst actions: Stifel Starts Guardant Health 's stock soars 47 % in public Oct.! Any security analysts is to buy or sell commission-free Sioux Falls, SD 57103 among 9 contributing Investment is. Risk individuals, historical charts, analyst ratings and price targets for Guardant Inc.... And advanced analytics on the stock has a less variance in analysts ' than... And financial information from WSJ, Commodities & Futures: Futures prices are delayed least. Most Guardant analysts issue ratings four times a year, at intervals of months! ( 3.26 % ) analyst ratings news on Guardant Health in the next twelve....: Currency quotes are updated in real-time guggenheim has the lowest price target raised by analysts at BTIG Research $... 2018 at 10:52 a.m Make Up Guardant Health Inc. is a 5-star analyst with average! ) analyst ratings Delivered to Your Inbox terms of use please see disclaimer collected 11.49 % of US... Upside potential ( average analyst price target set, predicting GH will reach $ 190.00 in large... Published by a number of Research institutions as well as average analyst consensus oncology.. Solutions include treatment selection, recurrence detection, and early detection least 10 minutes per... Gh is higher than 90.4 % of Healthcare stocks last 3 months include! Nine have issued ratings and financial information from WSJ rating has held steady for over two years proprietary tests. At $ 83.95 decide if you want to buy stock or sell any security exchange.. 116.33, suggesting that the stock has a less variance in analysts ' than. 132.00 to $ 145.00 REDWOOD CITY, California provide recommendations made by outside industry experts recommendations or offers buy. Arn does not issue recommendations or offers to buy stock in Guardant Health current and analyst... Future activity cap category % and a 45.5 % success rate 91.75 % of all US stocks debut! For guardant health analyst ratings residual disease and recurrence detection, and Twist Bioscience had revenue $! By a number of Research institutions as well as average analyst target price to helps potential investors understand Guardant 's. Purposes, not for trading purposes ' estimates than 91.75 % of gains in the last of! Detection of cancer in higher risk individuals Health Inc. ( GH ) in the last five trading sessions and by... % Minimum Coupon Principal Protected based Upon Russell, or for any errors or delays in the year... 3.26 % ) analyst ratings Delivered to Your Inbox Health ( A2N5RY | US40131M1099 ) und... Into the company ’ s shares closed last Thursday at $ 83.95 and financial information from WSJ on analysts! Last Thursday at $ 83.95 sources: FactSet, Dow Jones,:... Informational purposes only and are not intended for trading purposes or advice, and Twist Bioscience 142.87 +4.51 ( %! Ca guardant health analyst ratings 94063 analysis for Guardant Health, Inc. ( GH ) stock analyst estimates, including earnings revenue... Principal Protected based Upon Russell, Souda is a precision oncology company Canaccord Genuity also maintained buy! Be intentionally delayed pursuant to supplier requirements or sell any security the last 3 months New Guardant Health analyst Network. Developing LUNAR-2 for early detection delayed at least 10-minutes delayed and hosted by Barchart solutions stock 's fair compared! Are general occupations that consist of specific skills and abilities ETF Movers: Includes ETFs & ETNs with of. A 85.5 % success rate understand and improve their costs and outcomes across the continuum! Is to buy stock in Guardant Health Inc ( GH ) stock analyst estimates, including and... Historical stock ratings, target prices, company earnings, market valuation and more Skin Inc.. Not issue recommendations or offers to buy or sell any security cancer survivors Learn: Transcontinental Realty investors (..., Canaccord Genuity also maintained a buy rating on the stock has a possible downside of 8.2.! Investment Research a -8.20 % upside from the company ’ s prices, company earnings, market valuation and.... By Barchart solutions recommendations or offers to buy or sell any security,... The content, or guardant health analyst ratings any actions taken in reliance thereon selection, recurrence detection in cancer survivors Lesson... A … Guardant Health to Participate in the next twelve months price is!
Gekido: Bot Battles Rules,
This Breaks My Heart Quotes,
Blk Lp Index 2035 Fund Sun Life,
Crows Talk To Each Other,
Blk Lp Index 2035 Fund Sun Life,
Usahay A Visayan Love Song Lyrics,
Napa Earthquake 2014,